Study findings show that the standardized 6-month surveillance protocols for all patients with low-risk uveal melanoma may be ...

A new study finds that fragments of tumor DNA in a patient's bloodstream could show that they are at high risk of a melanoma ...

The “Real Housewives of Beverly Hills” star recently revealed that her dad has planned her funeral as her melanoma has spread ...

Immune checkpoint (IC) inhibitor drug holidays are safe in patients with metastatic melanoma who achieve an objective response (OR) during therapy, according to a study of more than 200 patients in ...

In January 2025, Melanoma Institute Australia announced a phase II, open label, randomised trial of ipilimumab and nivolumab ...

Sep. 16, 2024 — Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer ...

Neoadjuvant pepinemab treatment shows potential to enhance immune response and improve survival in metastatic melanoma and head and neck cancer. Vaccinex, Inc. announced promising findings ...

Recurrence-free survival rates were similar, even when patients quit adjuvant immunotherapy early, according to a new report.

A new implant safely triggers potent immune responses against hard-to-treat cancers showing "promise" for pancreatic and ...